Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Braxia Scientific Corp BRAXF


Primary Symbol: C.BRAX

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP... see more

Recent & Breaking News (CSE:BRAX)

Braxia Scientific Announces Symbol Change on OTC Markets to "BRAXF"

Canada NewsWire May 20, 2021

/R E P E A T -- Braxia Scientific Introduces the Braxia Institute, Turning Research to Clinical Action; Over 200 Physicians and Health Care Providers to Attend Braxia's Symposium on Rapid Acting Anti-Depressants/

Canada NewsWire May 20, 2021

Braxia Scientific Introduces the Braxia Institute, Turning Research to Clinical Action; Over 200 Physicians and Health Care Providers to Attend Braxia's Symposium on Rapid Acting Anti-Depressants

Canada NewsWire May 20, 2021

Braxia Scientific Opens First Ketamine Therapy Clinic in Quebec; Enters Joint Venture with Neurotherapy Montreal, A Leading Brain Injury Solutions Clinic for Adults and Children

Canada NewsWire May 13, 2021

Braxia Scientific Introduces "Braxia Health" a Growing Network of Clinics Leading Novel Psychedelic Research and Treatments for Mental Disorders

Canada NewsWire May 7, 2021

Braxia Scientific Corp. Comments on Prospective Class Proceeding

Canada NewsWire May 3, 2021

Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities

PR Newswire May 3, 2021

IIROC Trade Resumption - SHRM

Canada NewsWire April 23, 2021

Champignon Brands Announces Revocation of Cease Trade Orders

Canada NewsWire April 22, 2021

Champignon Brands Announces Filing of Listing Statement

Canada NewsWire March 26, 2021

Champignon Brands Restates Financial Statements and MD&A Files Listing Statement

Canada NewsWire March 11, 2021

/C O R R E C T I O N from Source -- Champignon Brands Inc./

Canada NewsWire March 11, 2021

Champignon Brands to Restate Financial Statements and MD&A has Prepared CSE Listing Statement

Canada NewsWire February 17, 2021

Dr. Roger McIntyre Announces Changes to the Board of Champignon Brands Inc.

Canada NewsWire February 4, 2021

New Rapid mood Screener (RMS) Screens for Manic Symptoms and Bipolar I Disorder Features to Address Unmet Clinical Need

Canada NewsWire February 3, 2021

Champignon Brands' Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression

Canada NewsWire January 25, 2021

Marijuana Biotech Could Be The Most Exciting Industry Of 2021

Livemoney January 21, 2021

Champignon Brands Announces New CFO and New General Counsel

Canada NewsWire January 11, 2021

Review of Bipolar Disorders Confirms Early Diagnosis and Treatment Can Improve Patient Quality of Life

Canada NewsWire January 8, 2021

Champignon Brands Updates Investors on Changes at the Top

Canada NewsWire November 24, 2020